The Liver Meeting 2025

Washington, DC, US 07 November 2025 - 11 November 2025

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

18 Dec 2025 by

The LIVE-SMART trial presented at AASLD 2025 shows that lactulose and Tai chi may prevent falls in individuals with cirrhosis and portal hypertension.

Lactulose, Tai chi prevent falls in patients with cirrhosis, portal hypertension

18 Dec 2025

Inebilizumab MITIGATEs flares in IgG4-RD with pancreatic, hepatobiliary involvement

15 Dec 2025 by

The post hoc subgroup analysis of the phase III MITIGATE trial shows the benefit of the humanized monoclonal anti-CD19 antibody inebilizumab in adults with IgG4-related disease (IgG4-RD) with pancreas, bile duct, and liver involvement at baseline.

Inebilizumab MITIGATEs flares in IgG4-RD with pancreatic, hepatobiliary involvement

15 Dec 2025